The Limited Times

Now you can see non-English news...

The price of Pfizer and Moderna vaccines billed to Europe on the rise?


The Financial Times had access to the contracts for the sale of vaccines on the Old Continent. The two laboratories could in particular play on

+ 25%.

This is the price increase that the Pfizer laboratory would have obtained for the last order placed by the European Union.

To a lesser extent, its competitor Moderna would also have revised its price list upwards.

This is what revealed this Sunday the Financial Times, which consulted the contract.

The Pfizer vaccine goes from 15.5 euros to 19.5 euros and that of Moderna from 19 euros to 21.5 euros, according to the British financial daily.

The rise comes as concern over the delta variant outbreak mounts and studies have shown that Moderna and Pfizer / BioNTech's vaccines should remain effective against this variant.

The European Commission declined to comment, emphasizing the confidentiality of contracts.

Contacted in turn, Pfizer and Moderna did not immediately react on Sunday.

Initial prices had leaked on Twitter

The Commission has always refused to communicate the price of the vaccines ordered. In December, a Belgian minister posted on Twitter - before erasing it - a table giving details of the amounts promised by her government to manufacturers for each of the six vaccines ordered, with the unit price in the EU: from 1.78 euros for the vaccine of the Swedish-British group AstraZeneca, to 18 US dollars (or 14.70 euros) for that of the American Moderna.

In May, the EU signed a new contract to purchase up to 1.8 billion doses of vaccine from BioNTech-Pfizer for delivery through 2023, without revealing the price. In early July, European Commission President Ursula von der Leyen announced that the European Union had reached its goal of having enough doses in July to vaccinate 70% of its adult population (336 million people).

The EU's joint vaccine purchasing program provided 330 million doses of the BioNTech-Pfizer vaccine, 100 million of AstraZeneca, 50 million of Moderna and 20 million of Johnson & Johnson. At the end of July, the Pfizer laboratory planned to sell this year for 33.5 billion dollars (28.23 billion euros) of vaccines against the Covid-19, that is to say much more than the 26 billion dollars (21.91 billion euros) on which the group had counted two months earlier. Moderna, in May, counted on annual sales of 19.5 billion dollars (16.43 billion euros).

Source: leparis

All life articles on 2021-08-01

Similar news:

You may like

Life/Entertain 2021-08-02T12:57:03.743Z
News/Politics 2021-08-03T17:13:04.396Z
News/Politics 2021-08-05T10:35:14.968Z
Business 2021-05-11T11:25:19.185Z

Trends 24h

Life/Entertain 2021-09-27T03:41:51.909Z


© Communities 2019 - Privacy